abdm
Four responses from 21 patients does not equal 100% .................
Cvac may achieve a simular outcome as Abagovomab in Cvac's phase 2b trial now that they are treating Patients in First or Second Remission but that will take time to evaluate because we are still recruiting for the trial.
http://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=prr&timeframe=Y&year=2007
14/03/2007 Phase IIa final results explanatory presentation 13 PDF -
14/03/2007 Phase IIa final results exceed expectations 3 PDF -
SP today, page-56
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |